ABT's Structural Heart, Rhythm Management and Neuromodulation businesses are likely to have driven its first-quarter 2025 ...

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

With a key regulatory approval secured in Europe, Abbott Laboratories is joining the race to commercialize technology that ...

Abbott took "a deliberately very different development path ... for the waveform" behind its Volt PFA system, said Dr.

Resonant Link Medical develops wireless power charging and data transfer technology for implants as they get smarter and ...

The latest trading session saw Abbott (ABT) ending at $124.50, denoting a -2% adjustment from its last day's close. The stock's change was more than the S&P 500's daily loss of 3.46%. Meanwhile, the ...

Market OverviewThe Global Smart Medical Devices Market is valued at USD 90.55 Billion in 2024 and is projected to reach a ...

A leader in Abbott's Heart Failure division announced that the company named Dr. Finn Gustafsson as the unit's chief medical ...

Abbott (NYSE: ABT) today announced data demonstrating substantial, sustained improvements with its TriClip system.

Pharmaceuticals were mostly spared on "Liberation Day," while medical devices were not, though the long-term impacts for both industries are far from clear. As President Donald Trump's executive order ...